McGill University Health Centre/Research Institute of the McGill University Health Centre
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, McGill University Health Centre/Research Institute of the McGill University Health Centre sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
McGill University Health Centre/Research Institute of the McGill University Health Centre: 9 sponsored US clinical trials, 1 recruiting.
McGill University Health Centre/Research Institute of the McGill University Health Centre sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prediction of Extubation Readiness, with 1 trials.
Top-decile sponsor footprint
McGill University Health Centre/Research Institute of the McGill University Health Centre ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
9 total, page 1 of 1
Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
NCT06190626
STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation
NCT04428944
Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery
NCT03461497
Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3
NCT04288271
Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)
NCT04421664
Breathing-Induced Myocardial Oxygenation Reserve
NCT03050346
Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior
NCT01909947
Prospective Research in Infants With Mild Encephalopathy
NCT01747863
Intervention to Improve Adherence in Teen Kidney Transplant
NCT01356277
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Therapeutic Areas
Where McGill University Health Centre/Research Institute of the McGill University Health Centre enrollment is open (later-stage tilt)
1 recruiting of 9 indexed (11% open); 5 completed (56%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Prediction of Extubation Readiness (1 trial), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
McGill University Health Centre/Research Institute of the McGill University Health Centre: open-pipeline peers nationwide
Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
McGill University Health Centre/Research Institute of the McGill University Health Centre sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 trials (± recruiting share)
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
- Amylyx Pharmaceuticals · 11% recruiting · 9 trials
Related
What to do with this McGill University Health Centre/Research Institute of the McGill University Health Centre page
9 registered trials is a research-attention snapshot, not an endorsement of McGill University Health Centre/Research Institute of the McGill University Health Centre or any single study.
- 1 of McGill University Health Centre/Research Institute of the McGill University Health Centre's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prediction of Extubation Readiness is the condition McGill University Health Centre/Research Institute of the McGill University Health Centre studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prediction of Extubation Readiness trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. McGill University Health Centre/Research Institute of the McGill University Health Centre pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.